<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoVâ€‘2 replication can also be inhibited by treatment with nucleoside analogues (usually administered as prodrug) that interfere with the RNA-dependent RNA synthesis needed to amplify the viral genome and to produce the subgenomic mRNAs. Nucleoside analogues under current investigation for the treatment of COVID-19 include ribavirin, favipiravir (T-705) and remdesivir (GS-5734).</p>
